Abstract:Objective The objective of this research was to create a machine learning predictive model that could be easily interpreted in order to precisely determine the risk of premature death in patients receiving intensive care after pulmonary inflammation. Methods In this study, information from the China intensive care units (ICU) Open Source database was used to examine data from 2790 patients who had infections between January 2019 and December 2020. A 7:3 ratio was used to randomly assign the whole patient population to training and validation groups. This study used six machine learning techniques: logistic regression, random forest, gradient boosting tree, extreme gradient boosting tree (XGBoost), multilayer perceptron, and K-nearest neighbor. A cross-validation grid search method was used to search the parameters in each model. Eight metrics were used to assess the models’ performance: accuracy, precision, recall, F1 score, area under the curve (AUC) value, Brier score, Jordon’s index, and calibration slope. The machine methods were ranked based on how well they performed in each of these metrics. The best-performing models were selected for interpretation using both the Shapley Additive exPlanations (SHAP) and Local interpretable model-agnostic explanations (LIME) interpretable techniques. Results A subset of the study cohort’s patients (120/1668, or 7.19%) died in the hospital following screening for inclusion and exclusion criteria. Using a cross-validated grid search to evaluate the six machine learning techniques, XGBoost showed good discriminative ability, achieving an accuracy score of 0.889 (0.874–0.904), precision score of 0.871 (0.849–0.893), recall score of 0.913 (0.890–0.936), F1 score of 0.891 (0.876–0.906), and AUC of 0.956 (0.939–0.973). Additionally, XGBoost exhibited excellent performance with a Brier score of 0.050, Jordon index of 0.947, and calibration slope of 1.074. It was also possible to create an interactive internet page using the XGBoost model. Conclusion By identifying patients at higher risk of early mortality, machine learning-based mortality risk prediction models have the potential to significantly improve patient care by directing clinical decision making and enabling early detection of survival and mortality issues in patients with pulmonary inflammation disease.

Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data

Analysis of Validation Performance of a Machine Learning Classifier in Interstitial Lung Disease Cases Without Definite or Probable Usual Interstitial Pneumonia Pattern on CT Using Clinical and Pathology-Supported Diagnostic Labels

Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease

A composite score based on cardiovascular parameters can predict the mortality risk of patients with newly diagnosed interstitial lung disease: A prospective observational study

Deep Learning for Predicting Acute Exacerbation and Mortality of Interstitial Lung Disease

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: the GAP-ILD Model

Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis

Interpretability-based machine learning for predicting the risk of death from pulmonary inflammation in Chinese intensive care unit patients

Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data

The alternative approach: genomic classifiers for prognostication in interstitial lung disease

A machine learning-based risk stratification tool for in-hospital mortality of intensive care unit patients with heart failure

Is It Possible To Identify A Phenotype Of Ild Patients With A Higher Risk Of Mortality?

S55 Derivation and Validation of a Simple Longitudinal Score Which Strongly Predicts Mortality in Interstitial Lung Disease (ild) Associated Pulmonary Hypertension (Ild-Ph)

Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease

Development of Predictive Risk Models for All-cause Mortality in Pulmonary Hypertension Using Machine Learning

A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids

Development of a scoring system with multidimensional markers for fibrosing interstitial lung disease

A machine learning-based prediction of hospital mortality in mechanically ventilated ICU patients

Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data

At-Admission Prediction of Mortality and Pulmonary Embolism in COVID-19 Patients Using Statistical and Machine Learning Methods: An International Cohort Study

A Machine Learning Application to Predict Early Lung Involvement in Scleroderma: A Feasibility Evaluation